NCT01023295
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
- Locations
-
- OXiGENE Investigational Site Los Angeles, California, United States
- OXiGENE Investigational Site Hong Kong
- OXiGENE Investigational Site Singapore
- OXiGENE Investigational Site Seoul, South Korea